|
2013-07-02 |
2013-07-01 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
82,756
+10.2%
108.87
US$1,066,192
|
82,756
+10.2%
|
108.87
|
US$1,066,192
|
|
|
2013-07-02 |
2013-07-01 |
S
Sale
|
Sullivan Ryan T
VP, General Counsel & Secr.
Officer
|
58,431
-5.3%
165.14
US$2,390,387
|
58,431
-5.3%
|
165.14
|
US$2,390,387
|
|
|
2013-04-01 |
2013-04-01 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
|
31,845
-22.5%
309.40
US$3,912,018
|
31,845
-22.5%
|
309.40
|
US$3,912,018
|
|
|
2013-03-06 |
2013-03-04 |
S
Sale
|
CONNAUGHTON JOHN
Non-Executive Director
|
10,590,608
-100.0%
13.47
US$142,655,490
|
10,590,608
-100.0%
|
13.47
|
US$142,655,490
|
|
|
2013-03-04 |
2013-03-01 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
1,666
-0.9%
13.38
US$22,293
|
1,666
-0.9%
|
13.38
|
US$22,293
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Officer
|
15,869
-9.8%
13.46
US$213,655
|
15,869
-9.8%
|
13.46
|
US$213,655
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Fenton Andrew
Senior V.P., CIO
Officer
|
1,390
-1.3%
13.46
US$18,715
|
1,390
-1.3%
|
13.46
|
US$18,715
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Cross Leland H
Senior V.P., Tech. Operations
Officer
|
1,324
-0.6%
13.46
US$17,826
|
1,324
-0.6%
|
13.46
|
US$17,826
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
1,747
-3.2%
13.46
US$23,521
|
1,747
-3.2%
|
13.46
|
US$23,521
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Rodriguez Rama Francisco
Senior V.P., Tech. Operations
Officer
|
820
-2.6%
13.46
US$11,040
|
820
-2.6%
|
13.46
|
US$11,040
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
4,674
-3.4%
13.46
US$62,929
|
4,674
-3.4%
|
13.46
|
US$62,929
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Boissonneault Roger M
CEO & President
Executive Director
|
18,730
-0.8%
13.46
US$252,175
|
18,730
-0.8%
|
13.46
|
US$252,175
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Fuhrmann Rochelle
Senior V.P., Finance
Officer
|
1,728
-3.0%
13.46
US$23,265
|
1,728
-3.0%
|
13.46
|
US$23,265
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
1,728
-1.7%
13.46
US$23,265
|
1,728
-1.7%
|
13.46
|
US$23,265
|
|
|
2013-03-01 |
2013-02-28 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
2,354
-2.9%
13.46
US$31,694
|
2,354
-2.9%
|
13.46
|
US$31,694
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Boissonneault Roger M
CEO & President
Executive Director
|
7,928
-0.3%
14.53
US$115,176
|
7,928
-0.3%
|
14.53
|
US$115,176
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
1,969
-1.4%
14.53
US$28,605
|
1,969
-1.4%
|
14.53
|
US$28,605
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Fenton Andrew
Senior V.P., CIO
Officer
|
419
-0.4%
14.53
US$6,087
|
419
-0.4%
|
14.53
|
US$6,087
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
1,045
-1.3%
14.53
US$15,181
|
1,045
-1.3%
|
14.53
|
US$15,181
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
767
-0.8%
14.53
US$11,143
|
767
-0.8%
|
14.53
|
US$11,143
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
419
-0.8%
14.53
US$6,087
|
419
-0.8%
|
14.53
|
US$6,087
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
691
-0.4%
14.53
US$10,039
|
691
-0.4%
|
14.53
|
US$10,039
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Fuhrmann Rochelle
Senior V.P., Finance
Officer
|
767
-1.3%
14.53
US$11,143
|
767
-1.3%
|
14.53
|
US$11,143
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Officer
|
2,562
-1.9%
14.53
US$37,220
|
2,562
-1.9%
|
14.53
|
US$37,220
|
|
|
2013-02-21 |
2013-02-19 |
S
Sale
|
Cross Leland H
Senior V.P., Tech. Operations
Officer
|
553
-0.3%
14.53
US$8,034
|
553
-0.3%
|
14.53
|
US$8,034
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Boissonneault Roger M
CEO & President
Executive Director
|
9,125
-0.4%
14.18
US$129,376
|
9,125
-0.4%
|
14.18
|
US$129,376
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Fuhrmann Rochelle
Senior V.P., Finance
Officer
|
998
-2.2%
14.18
US$14,150
|
998
-2.2%
|
14.18
|
US$14,150
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
1,010
-1.2%
14.18
US$14,320
|
1,010
-1.2%
|
14.18
|
US$14,320
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
2,840
-2.7%
14.18
US$40,266
|
2,840
-2.7%
|
14.18
|
US$40,266
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
998
-2.5%
14.18
US$14,150
|
998
-2.5%
|
14.18
|
US$14,150
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
1,377
-2.1%
14.18
US$19,523
|
1,377
-2.1%
|
14.18
|
US$19,523
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
1,010
-0.6%
14.18
US$14,320
|
1,010
-0.6%
|
14.18
|
US$14,320
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Fenton Andrew
Senior V.P., CIO
Officer
|
996
-1.0%
14.18
US$14,121
|
996
-1.0%
|
14.18
|
US$14,121
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
Cross Leland H
Senior V.P., Tech. Operations
Officer
|
808
-0.4%
14.18
US$11,456
|
808
-0.4%
|
14.18
|
US$11,456
|
|
|
2013-02-04 |
2013-02-01 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Officer
|
13,790
-9.4%
14.18
US$195,517
|
13,790
-9.4%
|
14.18
|
US$195,517
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Officer
|
308
-0.2%
13.38
US$4,122
|
308
-0.2%
|
13.38
|
US$4,122
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Fenton Andrew
Senior V.P., CIO
Officer
|
351
-0.4%
13.38
US$4,698
|
351
-0.4%
|
13.38
|
US$4,698
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
489
-0.7%
13.38
US$6,545
|
489
-0.7%
|
13.38
|
US$6,545
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
320
-0.8%
13.38
US$4,283
|
320
-0.8%
|
13.38
|
US$4,283
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
591
-0.7%
13.38
US$7,910
|
591
-0.7%
|
13.38
|
US$7,910
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Officer
|
1,907
-1.3%
14.42
US$27,499
|
1,907
-1.3%
|
14.42
|
US$27,499
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Cross Leland H
Senior V.P., Tech. Operations
Officer
|
465
-0.2%
13.38
US$6,224
|
465
-0.2%
|
13.38
|
US$6,224
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
586
-0.3%
13.38
US$7,843
|
586
-0.3%
|
13.38
|
US$7,843
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Fuhrmann Rochelle
Senior V.P., Finance
Officer
|
282
-0.6%
13.38
US$3,774
|
282
-0.6%
|
13.38
|
US$3,774
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
2,208
-2.1%
13.38
US$29,552
|
2,208
-2.1%
|
13.38
|
US$29,552
|
|
|
2013-01-31 |
2013-01-30 |
S
Sale
|
Boissonneault Roger M
CEO & President
Executive Director
|
8,470
-0.4%
13.38
US$113,363
|
8,470
-0.4%
|
13.38
|
US$113,363
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Boissonneault Roger M
CEO & President
Executive Director
|
13,924
-0.6%
13.50
US$187,973
|
13,924
-0.6%
|
13.50
|
US$187,973
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
949
-1.4%
13.50
US$12,811
|
949
-1.4%
|
13.50
|
US$12,811
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Cross Leland H
Senior V.P., Tech. Operations
Officer
|
839
-0.4%
13.50
US$11,326
|
839
-0.4%
|
13.50
|
US$11,326
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
4,305
-3.9%
13.50
US$58,117
|
4,305
-3.9%
|
13.50
|
US$58,117
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
488
-1.2%
13.50
US$6,588
|
488
-1.2%
|
13.50
|
US$6,588
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
1,222
-1.4%
13.50
US$16,497
|
1,222
-1.4%
|
13.50
|
US$16,497
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Fuhrmann Rochelle
Senior V.P., Finance
Officer
|
488
-1.1%
13.50
US$6,588
|
488
-1.1%
|
13.50
|
US$6,588
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Fenton Andrew
Senior V.P., CIO
Officer
|
621
-0.6%
13.50
US$8,383
|
621
-0.6%
|
13.50
|
US$8,383
|
|
|
2013-01-23 |
2013-01-22 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
1,166
-0.7%
13.50
US$15,741
|
1,166
-0.7%
|
13.50
|
US$15,741
|
|
|
2012-10-01 |
2012-10-01 |
S
Sale
|
Gilligan Claire A
Senior V.P., Quality
Officer
|
264
-0.4%
13.55
US$3,577
|
264
-0.4%
|
13.55
|
US$3,577
|
|
|
2012-10-01 |
2012-10-01 |
S
Sale
|
Halstead Michael
Senior V.P., Corp. Development
Officer
|
77
-0.2%
13.55
US$1,043
|
77
-0.2%
|
13.55
|
US$1,043
|
|
|
2012-09-13 |
2012-09-11 |
S
Sale
|
THL WC (Dutch) B.V.
Large shareholder
|
14,000,000
-54.9%
13.10
US$183,400,000
|
14,000,000
-54.9%
|
13.10
|
US$183,400,000
|
|
|
2012-09-13 |
2012-09-11 |
S
Sale
|
ABBRECHT TODD M
Non-Executive Director
|
14,000,000
-54.9%
13.10
US$183,400,000
|
14,000,000
-54.9%
|
13.10
|
US$183,400,000
|
|
|
2012-09-13 |
2012-09-11 |
S
Sale
|
CONNAUGHTON JOHN
Non-Executive Director
Large shareholder
|
12,890,449
-52.9%
13.10
US$168,864,882
|
12,890,449
-52.9%
|
13.10
|
US$168,864,882
|
|
|
2012-09-13 |
2012-09-11 |
S
Sale
|
BAIN CAPITAL INVESTORS LLC
Large shareholder
|
12,890,449
-52.9%
13.10
US$168,864,882
|
12,890,449
-52.9%
|
13.10
|
US$168,864,882
|
|
|
2012-09-12 |
2012-09-11 |
S
Sale
|
Herendeen Paul
Exec. V.P. and CFO
Officer
|
309,240
-73.6%
13.10
US$4,051,044
|
309,240
-73.6%
|
13.10
|
US$4,051,044
|
|
|
2012-09-12 |
2012-09-11 |
S
Sale
|
Hara Izumi
Senior V.P.
Officer
|
126,993
-63.2%
13.10
US$1,663,608
|
126,993
-63.2%
|
13.10
|
US$1,663,608
|
|
|
2012-09-12 |
2012-09-11 |
S
Sale
|
Ellman Herman
Senior V.P., Clinical Devel.
Officer
|
23,500
-12.1%
13.10
US$307,850
|
23,500
-12.1%
|
13.10
|
US$307,850
|
|
|
2012-09-12 |
2012-09-11 |
S
Sale
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Officer
|
147,639
-62.2%
13.10
US$1,934,071
|
147,639
-62.2%
|
13.10
|
US$1,934,071
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
1,497,803
-68.9%
13.10
US$19,621,219
|
1,497,803
-68.9%
|
13.10
|
US$19,621,219
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
215,401
-54.9%
13.10
US$2,821,753
|
215,401
-54.9%
|
13.10
|
US$2,821,753
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
950,124
-54.9%
13.10
US$12,446,624
|
950,124
-54.9%
|
13.10
|
US$12,446,624
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
193,470
-68.9%
13.10
US$2,534,457
|
193,470
-68.9%
|
13.10
|
US$2,534,457
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
1,145,303
-54.9%
13.10
US$15,003,469
|
1,145,303
-54.9%
|
13.10
|
US$15,003,469
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
266,987
-54.9%
13.10
US$3,497,530
|
266,987
-54.9%
|
13.10
|
US$3,497,530
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
373,782
-54.9%
13.10
US$4,896,544
|
373,782
-54.9%
|
13.10
|
US$4,896,544
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
2,224,741
-54.9%
13.10
US$29,144,107
|
2,224,741
-54.9%
|
13.10
|
US$29,144,107
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JPMP MASTER FUND MANAGER L P
Large shareholder
|
7,894,814
-54.9%
13.10
US$103,422,063
|
7,894,814
-54.9%
|
13.10
|
US$103,422,063
|
|
|
2012-09-11 |
2012-09-11 |
S
Sale
|
JP MORGAN PARTNERS BHCA LP
Large shareholder
|
1,497,803
-68.9%
13.10
US$19,621,219
|
1,497,803
-68.9%
|
13.10
|
US$19,621,219
|
|